These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. Wan S; Shukla N; Yim AP; Johnson JL; Angelini GD; Jeremy JY J Thorac Cardiovasc Surg; 2007 Feb; 133(2):494-500. PubMed ID: 17258588 [TBL] [Abstract][Full Text] [Related]
4. Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells. Hotston M; Jeremy JY; Bloor J; Greaves NS; Persad R; Angelini G; Shukla N Asian J Androl; 2008 Nov; 10(6):905-13. PubMed ID: 18097500 [TBL] [Abstract][Full Text] [Related]
5. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. Dashwood MR; Savage K; Tsui JC; Dooley A; Shaw SG; Fernández Alfonso MS; Bodin L; Souza DS J Thorac Cardiovasc Surg; 2009 Aug; 138(2):334-40. PubMed ID: 19619776 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525 [TBL] [Abstract][Full Text] [Related]
7. Does periadventitial fat-derived nitric oxide play a role in improved saphenous vein graft patency in patients undergoing coronary artery bypass surgery? Dashwood MR; Dooley A; Shi-Wen X; Abraham DJ; Souza DS J Vasc Res; 2007; 44(3):175-81. PubMed ID: 17308436 [TBL] [Abstract][Full Text] [Related]
8. Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes. Bloor J; Shukla N; Smith FC; Angelini GD; Jeremy JY Diabetologia; 2010 May; 53(5):980-8. PubMed ID: 20182861 [TBL] [Abstract][Full Text] [Related]
9. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. Jabs A; Göbel S; Wenzel P; Kleschyov AL; Hortmann M; Oelze M; Daiber A; Münzel T J Am Coll Cardiol; 2008 Jun; 51(22):2130-8. PubMed ID: 18510959 [TBL] [Abstract][Full Text] [Related]
11. The administration of folic acid reduces intravascular oxidative stress in diabetic rabbits. Shukla N; Angelini GD; Jeremy JY Metabolism; 2008 Jun; 57(6):774-81. PubMed ID: 18502259 [TBL] [Abstract][Full Text] [Related]
16. Copper and homocysteine in cardiovascular diseases. Kang YJ Pharmacol Ther; 2011 Mar; 129(3):321-31. PubMed ID: 21130114 [TBL] [Abstract][Full Text] [Related]
17. Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation. Glineur D; Hanet C; Poncelet A; D'hoore W; Funken JC; Rubay J; Astarci P; Lacroix V; Verhelst R; Etienne PY; Noirhomme P; El Khoury G J Thorac Cardiovasc Surg; 2008 Aug; 136(2):482-8. PubMed ID: 18692661 [TBL] [Abstract][Full Text] [Related]
18. Intermediate-term patency of saphenous vein graft with a clampless hand-sewn proximal anastomosis device after off-pump coronary bypass grafting. Shimokawa T; Manabe S; Sawada T; Matsuyama S; Fukui T; Takanashi S Ann Thorac Surg; 2009 May; 87(5):1416-20. PubMed ID: 19379877 [TBL] [Abstract][Full Text] [Related]
19. Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits. Hayward PA; Buxton BF Ann Thorac Surg; 2007 Sep; 84(3):795-9. PubMed ID: 17720377 [TBL] [Abstract][Full Text] [Related]
20. Effect of radial artery or saphenous vein conduit for the second graft on 6-year clinical outcome after coronary artery bypass grafting. Results of a randomised trial. Hayward PA; Hare DL; Gordon I; Buxton BF Eur J Cardiothorac Surg; 2008 Jul; 34(1):113-7. PubMed ID: 18455416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]